RETROPERITONEAL LYMPH NODE DISSECTION FOR THE MANAGEMENT OF CLINICAL STAGE I NONSEMINOMA
- 1 June 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 163 (6) , 1788-1792
- https://doi.org/10.1016/s0022-5347(05)67544-1
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- RESULTS OF RETROPERITONEAL LYMPH NODE DISSECTION IN CLINICAL STAGE I PURE YOLK SAC TUMOR IN ADULTSJournal of Urology, 1999
- Secondary leukemia following high cumulative doses of etoposide in patients treated for advanced germ cell tumors.Journal of Clinical Oncology, 1998
- Identification of clinical stage A nonseminomatous testis cancer patients at extremely low risk for metastatic disease: a combined approach using quantitive immunohistochemical, histopathologic, and radiologic assessment.Journal of Clinical Oncology, 1998
- Evaluation of long-term toxicity after chemotherapy for testicular cancer.Journal of Clinical Oncology, 1996
- Clinical stage B non-seminomatous germ cell testis cancer: The Indiana University experience (1965–1989) using routine primary retroperitoneal lymph node dissectionEuropean Journal Of Cancer, 1995
- Late relapse of testicular cancer.Journal of Clinical Oncology, 1995
- The Fertility of Patients with Clinical Stage I Testis Cancer Managed by Nerve Sparing Retroperitoneal Lymph Node DissectionJournal of Urology, 1994
- Primary Retroperitoneal Lymph Node Dissection in Clinical Stage A Non‐seminomatous Germ Cell Testis Cancer Review of the Indiana University Experience 1965–1989British Journal of Urology, 1993
- Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party.Journal of Clinical Oncology, 1992
- Is adjuvant chemotherapy necessary for patients with stage B1 testicular cancer?Journal of Clinical Oncology, 1991